- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccinia-based vaccines to biothreat and emerging viruses
Authors
Keywords
-
Journal
Biotechnology & Genetic Engineering Reviews
Volume 34, Issue 1, Pages 107-121
Publisher
Informa UK Limited
Online
2018-05-21
DOI
10.1080/02648725.2018.1471643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments
- (2018) Ryan S. Noyce et al. PLoS One
- Vaccinia virus evasion of regulated cell death
- (2017) David L. Veyer et al. IMMUNOLOGY LETTERS
- Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles
- (2017) Marc Schweneker et al. JOURNAL OF VIROLOGY
- Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology
- (2017) Preethi Eldi et al. MOLECULAR THERAPY
- Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
- (2017) Linda S. Wyatt et al. mBio
- Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses
- (2017) Chad R. Irwin et al. Frontiers in Oncology
- Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery
- (2017) Dana Haddad Frontiers in Oncology
- Multivalent and Multipathogen Viral Vector Vaccines
- (2016) Katharina B. Lauer et al. Clinical and Vaccine Immunology
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chikungunya Virus Vaccines: Viral Vector–Based Approaches: Table 1.
- (2016) Katrin Ramsauer et al. JOURNAL OF INFECTIOUS DISEASES
- Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators
- (2016) Rebecca P. Sumner et al. VACCINE
- Status of research and development of vaccines for chikungunya
- (2016) Claire Smalley et al. VACCINE
- Yellow fever
- (2015) Thomas P. Monath et al. JOURNAL OF CLINICAL VIROLOGY
- Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates
- (2015) Juan García-Arriaza et al. JOURNAL OF VIROLOGY
- The Evolution of Poxvirus Vaccines
- (2015) Lucas Sánchez-Sampedro et al. Viruses-Basel
- A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice
- (2015) Christopher Weber et al. PLoS Neglected Tropical Diseases
- A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis
- (2015) Richard N Greenberg et al. PLoS One
- Strikingly poor CD8+ T-cell immunogenicity of vaccinia virus strain MVA in BALB/c mice
- (2014) Tiffany A Russell et al. IMMUNOLOGY AND CELL BIOLOGY
- A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection
- (2014) J. Garcia-Arriaza et al. JOURNAL OF VIROLOGY
- Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine
- (2014) Mookkan Prabakaran et al. PLoS One
- IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection
- (2014) S. A. Valkenburg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals
- (2014) Sharon E. Frey et al. VACCINE
- Enhancing poxvirus vectors vaccine immunogenicity
- (2014) Juan García-Arriaza et al. Human Vaccines & Immunotherapeutics
- Recombinant Modified Vaccinia Virus Ankara Expressing Glycoprotein E2 of Chikungunya Virus Protects AG129 Mice against Lethal Challenge
- (2014) Petra van den Doel et al. PLoS Neglected Tropical Diseases
- A Novel MVA Vectored Chikungunya Virus Vaccine Elicits Protective Immunity in Mice
- (2014) James Weger-Lucarelli et al. PLoS Neglected Tropical Diseases
- Clinical applications of attenuated MVA poxvirus strain
- (2013) Carmen Elena Gómez et al. Expert Review of Vaccines
- Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
- (2013) G. L. Smith et al. JOURNAL OF GENERAL VIROLOGY
- Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways
- (2013) Juan García-Arriaza et al. PLoS One
- A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses
- (2013) Sonia T. Wennier et al. PLoS One
- Recombinant MVA vaccines: dispelling the myths
- (2013) Matthew G. Cottingham et al. VACCINE
- MVA and NYVAC as Vaccines against Emergent Infectious Diseases and Cancer
- (2011) Carmen E. Gomez et al. CURRENT GENE THERAPY
- Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
- (2011) Birgit Schäfer et al. PLoS One
- Improved NYVAC-Based Vaccine Vectors
- (2011) Karen V. Kibler et al. PLoS One
- Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses
- (2010) K. Baur et al. JOURNAL OF VIROLOGY
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
- (2010) Wataru Akahata et al. NATURE MEDICINE
- A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
- (2009) Alfred von Krempelhuber et al. VACCINE
- Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine
- (2008) Audrey Ferrier-Rembert et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search